Issues related to the economic analysis of genomic diagnostic technologies in the UK National Health Service: an exploration of methods by Buchanan, J

Evaluating the outcomes associated with genomic sequencing: a roadmap for future research by Buchanan, J, Wordsworth, S

A review of health economic studies comparing traditional and massively parallel sequencing diagnostic pathways for suspected genetic disorders by Fahr, P, Buchanan, J, Wordsworth, S

The impact of hospital costing methods on cost-effectiveness analysis: a case study by Leal, J, Manetti, S, Buchanan, J

Issues surrounding the health economic evaluation of genomic technologies. by Buchanan, J, Wordsworth, S, Schuh, A

Patients’ preferences for genomic diagnostic testing in chronic lymphocytic leukaemia: a discrete choice experiment by Buchanan, J, Wordsworth, S, Schuh, A

A review of the challenges of using biomedical big data for economic evaluations of precision medicine by Fahr, P, Buchanan, J, Wordsworth, S

MANAGING THE LONG-TERM CARE OF INFLAMMATORY BOWEL DISEASE PATIENTS: THE COST TO EUROPEAN HEALTH CARE PROVIDERS by Buchanan, J, Wordsworth, S, Taylor, J, Jewell, D

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature by Schwarze, K, Buchanan, J, Taylor, J, Wordsworth, S

Are whole exome and whole genome sequencing approaches cost-effective? A systematic review of the literature by Schwarze, K, Buchanan, J, Taylor, J, Wordsworth, S

The development of an Australian teacher performance assessment: lessons from the international literature by Stacey, M, Talbot, D, Buchanan, J, Mayer, D

What aspects of illness influence public preferences for healthcare priority setting? a discrete choice experiment in the UK by Morrell, L, Buchanan, J, Rees, S, Barker, R, Wordsworth, S

Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness. by Buchanan, J, Mihaylova, B, Gray, A, White, N

Worldwide exome and genome sequencing: who has access, who pays, and what are solutions for implementation challenges? by Phillips, K, Douglas, M, Wordsworth, S, Buchanan, J, Marshall, D

Valuation of health and nonhealth outcomes from next-generation sequencing: Approaches, challenges, and solutions by Regier, D, Weymann, D, Buchanan, J, Marshall, D, Wordsworth, S

Availability and funding of clinical genomic sequencing globally by Phillips, KA, Douglas, MP, Wordsworth, S, Buchanan, J, Marshall, DA

Use of decision modelling in economic evaluations of diagnostic tests: an appraisal and review of Health Technology Assessments in the UK by Yang, Y, Abel, L, Buchanan, J, Fanshawe, T, Shinkins, B

Surgery versus surveillance in ulcerative colitis patients with endoscopically invisible low-grade dysplasia: a cost-effectiveness analysis by Parker, B, Buchanan, J, Wordsworth, S, Keshav, S, George, B, East, J

Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories. by Wordsworth, S, Papanicolas, I, Buchanan, J, Frayling, I, Taylor, J, Tomlinson, I

Current and future molecular testing of cancers: A survey of UK laboratories by Papanicolas, I, Wordsworth, S, Buchanan, J, Taylor, J, Frayling, I, Tomlinson, I